Protoporphyrin IX occurs naturally in colorectal cancers and their metastases

Cancer Research

Volumn 61, Issue 3, 2001, Pages 991-999

  Moesta, K Thomas ^a   Ebert, Bernd ^b   Handke, Tim ^a   Nolte, Dirk ^b   Nowak, Christian ^a   Haensch, Wolfgang E ^a   Pandey, Ravindra K ^c   Dougherty, Thomas J ^c   Rinneberg, Herbert ^b   Schlag, Peter M ^a  

^a Section of Pathology   (Germany)

^b PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MESENTERY LYMPH NODE; METASTASIS; PRIORITY JOURNAL; TISSUE SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGAN SPECIFICITY; PROTOPORPHYRINS; SPECTROMETRY, FLUORESCENCE;

EID: 0035111005     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Fluorescence detection of tumors. Early diagnosis of microscopic lesions in preclinical studies
2. Photodetection and photodynamic therapy of 'early' squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree
3. Etudes sur les aspects offerts par les tumeurs experimentales examinees a la lumiere de woods
4. The fluorescence of cancer under the wood's light
5. Porphyfin fluorescence of experimentally produced squamous cell carcinoma
6. Endogenous porphyrin fluorescence in tumors
7. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
8. Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study
9. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: Preliminary results
10. Inhalation of 5-aminolevulinic acid: A new technique for fluorescence detection of early stage lung cancer
11. Characteristic porphyrin-like autofluorescence in primary colon tumors and lymph nodes
12. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: A Phase II clinical trial
13. An assay for the quantitation of Photofrin in tissues and fluids
14. Photophysics of and instrumentation for porphyrin detection and activation
15. Detection of an endogenous chromophore in colorectal lymph node metastases by time-delayed fluorescence measurement
16. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats
17. The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders
18. Mechanisms of toxicity of photoactivated artificial porphyrins. Role of porphyrin-protein interactions
19. Porphyrin metabolism in some malignant diseases
20. Heme-biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat
21. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase
22. The biochemical approach to cancer therapy: A short essay
23. Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo
24. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin
25. Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: A study in patients with (pre)malignant lesions of the oesophagus
26. A regulatory role for porphobilinogen deaminase (PBGD) in Δ-aminolaevulinic acid (Δ-ALA)-induced photosensitization?
27. Delayed observation of laser-induced fluorescence for imaging of tumors
28. The surgical treatment of cancer of the sigmoid flexure and rectum
29. A method of performing abdominopelvic excision for carcinoma of the rectum and of the terminal portion of the pelvic colon
30. Indication for using high ligation of the inferior mesenteric artery in rectal cancer surgery. Examination of nodal metastases by the clearing method
31. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer
32. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection
33. Lateral lymph node dissection for rectal carcinoma below the peritoneal reflection
34. Radical abdominopelvic lymphadenectomy: Historic perspective and current role in the surgical management of rectal cancer
35. No-touch isolation technique in colon cancer: A controlled prospective trial
36. Relationship of apical lymph node involvement to survival in resected colon carcinoma
37. Radioimmunoguided surgery for colorectal cancer
38. Radioimmunoguided surgery benefits for recurrent colorectal cancer
39. Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancer
40. Development of human anti-murine antibody (HAMA) response in patients
41. Metastases from carcinoma of the colon and rectum detected in small lymph nodes by the clearing method
42. The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer
43. Prognostic profile in rectal cancer
44. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival
45. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma
46. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer
47. Genetic diagnosis of lymph-node metastasis in colorectal cancer
48. Micrometastases and survival in stage II colorectal cancer